RESUMO
The ABAC System, as it is currently configured, uses pre-determined panels of antibiotics. This form of presentation is a limit for the use of the large number of new molecules, mainly active on Gram-negative bacteria. Therefore, the introduction of a new disposable, called "Gram-negative bacteria--new molecules" is suggested. Such a device will contain those additional and more widely tested antibiotics. According to recent studies concerning the pathology of Gram-positive organisms and the chemotherapeutic treatment for such pathology, changes in the disposable formulations for staphylococci and streptococci are proposed.
Assuntos
Antibacterianos/farmacologia , Bactérias Gram-Negativas/efeitos dos fármacos , Testes de Sensibilidade Microbiana/métodos , Lactamas , Kit de Reagentes para DiagnósticoRESUMO
ABAC- IDENTIBIOGRAMMA II is a new system allowing the carry out of antimicrobial susceptibility testing on various bacterial groups and also the fully automatic simultaneous susceptibility testing and identification of Gram-negative bacilli (urinary and not). Particularly most species of Enterobacteriaceae and Aeromonas hydrophila, Acinetobacter sp., Pseudomonas sp. can be identified. This system has two important characteristics, due to a computerized program: that is the possibility of using sensitivity data as complement of the biochemical assays to obtain identification and the directions for use transmitted through the display. The validity of system and the reliability of its results have been verified.